Refine your search

Search

    Filter by

    Location
      Age (years)
      Sex

      Show filters

      Join PfizerLink — a clinical research registry

      Get notified about clinical trials that may be right for you — now and over time. Share some information about your health and medical areas of interest. We’ll reach out if a Pfizer clinical trial may be a fit.

      Sickle Cell Disease clinical trial

      The DREAM study is exploring whether a study medicine can reduce symptoms and improve the overall health of people with Sickle Cell Disease.

      23 trials found for Lung cancer, Lung Neoplasm, Lung Carcinoma

      All(23)
      Recruiting(20)
      Not yet recruiting(3)
      Recruiting
      NCT06012435
      A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer

      Carcinoma, Non-Small-Cell Lung

      Male or Female
      18+ years
      77study location(s)
      Recruiting
      NCT05355701
      A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.

      Melanoma, Non-Small-Cell Lung Cancer, Thyroid Cancer, Glioma

      Male or Female
      16+ years
      88study location(s)
      Recruiting
      NCT05194072
      A Study of SGN-B7H4V in Advanced Solid Tumors

      Ovarian Neoplasms, Peritoneal Neoplasms, Fallopian Tube Neoplasms, Triple Negative Breast Neoplasms, HER2 Negative Breast Neoplasms, Hormone Receptor Positive Breast Neoplasms, Endometrial Neoplasms, Carcinoma, Non-Small-Cell Lung,

      Male or Female
      18+ years
      19study location(s)
      Recruiting
      NCT04609566
      Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

      Melanoma, Non-small Cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck

      Male or Female
      18+ years
      27study location(s)
      Recruiting
      NCT05571839
      A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors

      Cutaneous Melanoma, Non-small Cell Lung Cancer, Colorectal Neoplasms, Pancreatic Neoplasms, Mesothelioma

      Male or Female
      18+ years
      19study location(s)
      Recruiting
      NCT06448364
      A Study in Advanced/Metastatic Solid Tumors With the Study Medicine (PF-07329640) When Given Alone or In Combination

      Advanced or Metastatic Solid Tumors, Non-Small Cell Lung Cancer, Colorectal Cancer, Urothelial Cancer, Melanoma

      Male or Female
      18+ years
      8study location(s)
      Recruiting
      NCT06131840
      A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

      Colorectal Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Pancreatic Ductal Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Small Cell Lung Carcinoma

      Male or Female
      18+ years
      10study location(s)
      Recruiting
      NCT05144997
      Lorlatinib Continuation Study

      Non-Small-Cell Lung Cancer, NSCLC

      Male or Female
      18+ years
      54study location(s)
      Recruiting
      NCT06285097
      A Study of PF-07820435 as a Single Agent and in Combination in Participants With Advanced Solid Tumors

      Neoplasms, Non-small-cell Lung Cancer, Melanoma, Squamous Cell Carcinoma of the Head and Neck, Renal Cell Carcinoma, Urothelial Carcinoma, Colorectal Carcinoma, Ovarian Carcinoma

      Male or Female
      18+ years
      24study location(s)
      Recruiting
      NCT05538130
      A Study to Learn About the Study Medicine Called PF-07799544 in People With Advanced Solid Tumors

      Melanoma, Glioma, Thyroid Cancer, Non-Small Cell Lung Cancer, Malignant Neoplasms, Brain Neoplasms, Colorectal Cancer

      Male or Female
      16+ years
      58study location(s)

      Saved trials

      Saved trials

      You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.

      All(23)
      Recruiting(20)
      Not yet recruiting(3)

      Contact us

      For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.